Hemp-derived Cannabidiol Market Research Report 2033

Hemp-derived Cannabidiol Market Research Report 2033

Segments - by Product Type (Oils, Tinctures, Capsules, Topicals, Edibles, Others), by Application (Pharmaceuticals, Personal Care & Cosmetics, Food & Beverages, Nutraceuticals, Others), by Distribution Channel (Online Retail, Pharmacies, Specialty Stores, Others), by End-User (Adults, Geriatric, Pediatric, Others)

https://growthmarketreports.com/Anuradha
Author : Anuradha B. More
https://growthmarketreports.com/Vaibhav
Fact-checked by : Vaibhav Chandola
https://growthmarketreports.com/Shruti
Editor : Shruti Bhat

Upcoming | Report ID :FB-1511 | 4.9 Rating | 51 Reviews | 299 Pages | Format : Docx PDF

Report Description


Hemp-derived Cannabidiol (CBD) Market Outlook

According to our latest research, the global hemp-derived cannabidiol (CBD) market size reached USD 8.9 billion in 2024, reflecting robust growth driven by increasing consumer acceptance and expanding applications. The market is projected to grow at a CAGR of 20.7% from 2025 to 2033, with the market forecasted to reach USD 60.8 billion by 2033. This rapid expansion is underpinned by rising demand for natural wellness products, favorable regulatory shifts, and broadening distribution channels across both developed and emerging markets.

One of the primary growth factors for the hemp-derived cannabidiol (CBD) market is the growing consumer awareness regarding the health and therapeutic benefits of CBD products. As scientific research continues to validate the efficacy of cannabidiol for managing conditions such as anxiety, chronic pain, epilepsy, and inflammation, a wider demographic is turning to CBD as a natural alternative to traditional pharmaceuticals. The destigmatization of cannabis-derived products, coupled with aggressive marketing and education initiatives by industry players, is also playing a critical role in shifting consumer perceptions and boosting adoption rates. Furthermore, the increasing prevalence of lifestyle-related disorders and mental health issues globally is creating a sustained demand for CBD-infused products, particularly in the pharmaceuticals and nutraceuticals segments.

Regulatory advancements represent another significant driver for the global hemp-derived CBD market. Over the past few years, several countries have relaxed their regulations regarding the cultivation, processing, and sale of hemp-derived CBD products. Notably, the United States Farm Bill of 2018, which legalized industrial hemp at the federal level, has set a precedent for other regions to follow suit. This regulatory clarity has facilitated investments, encouraged innovation, and enabled the entry of new players into the market, thereby intensifying competition and driving product diversification. Additionally, governments and health authorities are increasingly recognizing the potential of CBD to address public health challenges, further supporting the integration of CBD into mainstream healthcare and wellness regimes.

Technological advancements and product innovation are also fueling the expansion of the hemp-derived CBD market. Leading manufacturers are investing heavily in research and development to create novel delivery formats, improve bioavailability, and enhance the efficacy of CBD products. The emergence of new product categories such as water-soluble CBD, nano-emulsified tinctures, and functional edibles is catering to evolving consumer preferences for convenience, taste, and effectiveness. Moreover, the integration of CBD into personal care, cosmetics, and food and beverage products is widening the scope of applications, attracting new consumer segments, and supporting market growth. Strategic collaborations between CBD producers and established brands in the food, beverage, and cosmetics industries are further accelerating the mainstream adoption of hemp-derived CBD products.

From a regional perspective, North America remains the dominant market for hemp-derived cannabidiol, accounting for over 48% of global revenue in 2024. The region's leadership is attributed to favorable regulatory frameworks, high consumer awareness, and a well-established distribution network. Europe is also experiencing significant growth, driven by progressive regulatory changes and increasing demand for wellness products. The Asia Pacific region, although still emerging, is witnessing rapid adoption fueled by rising health consciousness and expanding urban populations. Latin America and the Middle East & Africa are gradually opening up to CBD products, with local players and international brands actively exploring untapped opportunities in these regions.

Global Hemp-derived Cannabidiol Industry Outlook

Product Type Analysis

The hemp-derived cannabidiol (CBD) market is segmented by product type into oils, tinctures, capsules, topicals, edibles, and others. Among these, CBD oils continue to dominate the market, accounting for the largest share due to their versatility, ease of use, and high bioavailability. Consumers increasingly prefer oils for both oral and sublingual administration, as they offer precise dosing and rapid onset of effects. The growing body of clinical evidence supporting the efficacy of CBD oils for a variety of health conditions, including anxiety, pain, and sleep disorders, has further cemented their position as the flagship product category in the market. Moreover, the availability of full-spectrum, broad-spectrum, and isolate formulations caters to diverse consumer preferences and regulatory requirements across different geographies.

Tinctures are another popular product type, particularly among health-conscious consumers seeking convenient and fast-acting solutions. Tinctures are typically formulated with carrier oils and natural flavorings, making them palatable and easy to incorporate into daily routines. The sublingual administration method allows for quick absorption into the bloodstream, providing rapid relief for conditions such as stress and insomnia. The increasing trend of micro-dosing and personalized wellness regimens is also driving demand for tinctures, as they offer flexibility in dosing and can be easily adjusted to individual needs. Manufacturers are responding to this trend by launching a wide range of tincture products with varying concentrations, flavors, and functional additives.

CBD capsules and softgels are gaining traction, particularly among consumers who prioritize convenience, discretion, and precise dosing. Capsules are favored by individuals who may be averse to the taste of oils or tinctures and prefer a familiar delivery format akin to traditional supplements. The pharmaceutical-grade manufacturing processes employed in capsule production ensure consistent quality and potency, which is critical for consumers using CBD for therapeutic purposes. The rising popularity of CBD capsules is also supported by the growing acceptance of CBD as a dietary supplement, with many brands positioning their products as part of daily wellness routines.

Topicals and edibles represent rapidly expanding segments within the hemp-derived CBD market. Topicals, including creams, balms, and lotions, are increasingly used for localized relief of pain, inflammation, and skin conditions. The integration of CBD into skincare and cosmetic products is attracting a new demographic of beauty and wellness consumers, driving product innovation and premiumization. Edibles, such as gummies, chocolates, and beverages, offer a discreet and enjoyable way to consume CBD, appealing to younger consumers and those new to CBD. The growing trend of functional foods and beverages is expected to further propel the edibles segment, with manufacturers exploring novel formulations and flavor profiles to differentiate their offerings in a crowded marketplace.

Report Scope

Attributes Details
Report Title Hemp-derived Cannabidiol Market Research Report 2033
By Product Type Oils, Tinctures, Capsules, Topicals, Edibles, Others
By Application Pharmaceuticals, Personal Care & Cosmetics, Food & Beverages, Nutraceuticals, Others
By Distribution Channel Online Retail, Pharmacies, Specialty Stores, Others
By End-User Adults, Geriatric, Pediatric, Others
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2024
Historic Data 2018-2023
Forecast Period 2025-2033
Number of Pages 299
Number of Tables & Figures 350
Customization Available Yes, the report can be customized as per your need.

Application Analysis

The application landscape for hemp-derived cannabidiol is broad and diverse, encompassing pharmaceuticals, personal care and cosmetics, food and beverages, nutraceuticals, and others. The pharmaceuticals segment currently holds a significant share of the market, driven by the increasing adoption of CBD-based medications for the treatment of epilepsy, chronic pain, and neurodegenerative disorders. Regulatory approvals for CBD-based drugs, such as Epidiolex for epilepsy, have validated the therapeutic potential of cannabidiol and paved the way for further research and commercialization. Pharmaceutical companies are actively investing in clinical trials to explore new indications for CBD, which is expected to drive long-term growth in this segment.

The personal care and cosmetics segment is experiencing exponential growth, fueled by the rising demand for natural and plant-based ingredients in skincare and beauty products. CBD is recognized for its anti-inflammatory, antioxidant, and soothing properties, making it an attractive ingredient for formulations targeting sensitive skin, acne, and aging. Leading beauty brands are incorporating CBD into a wide range of products, including serums, moisturizers, masks, and bath products, to capitalize on the wellness trend and cater to discerning consumers. The increasing availability of premium and luxury CBD-infused cosmetics is also contributing to the segment's rapid expansion.

Food and beverages represent a dynamic and fast-evolving application segment for hemp-derived CBD. The legalization of CBD in food and beverage products in several countries has opened up new avenues for innovation and market penetration. CBD-infused beverages, such as sparkling water, teas, and energy drinks, are gaining popularity among health-conscious consumers seeking functional benefits and relaxation. Similarly, CBD edibles, including gummies, chocolates, and baked goods, are becoming mainstream, with manufacturers focusing on taste, quality, and consistent dosing. The convergence of health, wellness, and convenience is expected to drive continued growth in the food and beverage segment.

Nutraceuticals are another key application area, with CBD being increasingly incorporated into dietary supplements, vitamins, and functional foods. The growing consumer interest in preventive healthcare and holistic wellness is fueling demand for CBD nutraceuticals, which are marketed for their potential to support immune function, stress management, and overall vitality. The segment is characterized by a high degree of product innovation, with companies developing targeted formulations for specific health outcomes. The expansion of retail distribution channels and the increasing availability of CBD nutraceuticals in mainstream outlets are further supporting market growth.

Distribution Channel Analysis

The distribution landscape for hemp-derived cannabidiol products is rapidly evolving, with online retail, pharmacies, specialty stores, and other channels playing pivotal roles in market expansion. Online retail has emerged as the leading distribution channel, accounting for a significant share of global sales. The convenience of online shopping, coupled with a wide selection of products and competitive pricing, has made e-commerce platforms the preferred choice for many consumers. Online channels also offer educational resources, customer reviews, and product comparisons, empowering consumers to make informed purchasing decisions. The COVID-19 pandemic further accelerated the shift toward online retail, with many brands investing in direct-to-consumer (DTC) strategies and digital marketing to reach new audiences.

Pharmacies are a critical distribution channel, particularly for consumers seeking medical-grade CBD products and expert guidance. The inclusion of CBD products in pharmacy chains and independent drugstores has enhanced accessibility and credibility, encouraging adoption among health-conscious and older demographics. Pharmacists play a key role in educating consumers about proper usage, dosing, and potential interactions, which is essential for building trust and ensuring safe consumption. The integration of CBD into pharmacy retail is also supported by regulatory frameworks in many countries, which mandate quality standards and product labeling requirements.

Specialty stores, including health food stores, wellness boutiques, and cannabis dispensaries, are important channels for hemp-derived CBD products, offering curated selections and personalized service. These stores cater to consumers seeking premium, artisanal, or niche products, and often provide in-depth product information and sampling opportunities. The experiential nature of specialty retail, combined with knowledgeable staff and community engagement, creates a unique value proposition that differentiates these channels from mass-market retailers. As consumer preferences continue to evolve, specialty stores are likely to play an increasingly important role in brand building and customer loyalty.

Other distribution channels, such as supermarkets, convenience stores, and fitness centers, are gradually expanding their CBD offerings to capture a broader audience. The mainstreaming of CBD products in these outlets reflects growing consumer acceptance and the normalization of CBD as part of everyday wellness routines. Strategic partnerships between CBD brands and major retail chains are facilitating wider distribution and driving incremental growth. However, regulatory variability and the need for compliance with local laws remain challenges for CBD brands seeking to expand through these channels.

End-User Analysis

The end-user segmentation of the hemp-derived cannabidiol market includes adults, geriatric, pediatric, and other groups. Adults constitute the largest end-user segment, driven by high levels of health consciousness, stress, and lifestyle-related health issues. The adult population is increasingly turning to CBD products for relaxation, pain management, and overall wellness, fueled by effective marketing campaigns and growing social acceptance. The availability of a wide range of product formats, from oils and tinctures to edibles and topicals, caters to diverse preferences and consumption habits within this demographic. As the stigma surrounding cannabis-derived products continues to diminish, adult consumers are expected to remain the primary drivers of market growth.

The geriatric segment is witnessing significant growth, as older adults seek natural alternatives to manage chronic pain, arthritis, sleep disorders, and age-related health conditions. CBD's anti-inflammatory and analgesic properties make it an attractive option for seniors looking to improve their quality of life without the side effects associated with conventional medications. The increasing availability of low-dose and easy-to-administer products, such as capsules and topicals, is enhancing adoption among the elderly. Educational initiatives by healthcare providers and advocacy groups are also playing a crucial role in raising awareness and dispelling misconceptions about CBD use in this demographic.

Pediatric applications of hemp-derived CBD are primarily focused on the treatment of rare and severe medical conditions, such as epilepsy and certain neurodevelopmental disorders. The approval of CBD-based medications for pediatric use, such as Epidiolex, has provided a lifeline for children and families affected by treatment-resistant conditions. However, the use of CBD in pediatric populations is subject to stringent regulatory oversight and requires careful monitoring by healthcare professionals. Ongoing clinical research is exploring the safety and efficacy of CBD for a broader range of pediatric indications, which could expand the market for this end-user segment in the coming years.

Other end-user groups include athletes, wellness enthusiasts, and individuals with specific health needs. Athletes are increasingly using CBD for muscle recovery, pain relief, and performance enhancement, supported by endorsements from professional sports organizations and regulatory bodies. Wellness enthusiasts are drawn to the holistic and preventive health benefits of CBD, incorporating it into daily self-care routines. The ongoing diversification of product offerings and targeted marketing campaigns are expected to drive further growth across these niche end-user segments.

Opportunities & Threats

The hemp-derived cannabidiol market is rife with opportunities, particularly in the areas of product innovation, new applications, and geographic expansion. As scientific understanding of CBD's therapeutic potential continues to evolve, new product formulations and delivery methods are emerging, catering to diverse consumer needs and preferences. The integration of CBD into mainstream food, beverage, and personal care products presents significant growth opportunities for manufacturers and brands. Additionally, the gradual relaxation of regulatory restrictions in emerging markets, such as Asia Pacific and Latin America, is opening up new avenues for market entry and expansion. Strategic partnerships between CBD producers and established players in the pharmaceuticals, cosmetics, and food industries are also creating synergies and accelerating the commercialization of innovative products.

Another major opportunity lies in the development of medical-grade and pharmaceutical CBD products. The increasing acceptance of CBD as a legitimate therapeutic agent is driving investments in clinical research and drug development. Companies that can demonstrate the safety, efficacy, and quality of their CBD products through rigorous scientific validation are well-positioned to capture a share of the growing medical and pharmaceutical markets. Moreover, the rising demand for personalized and targeted wellness solutions is creating opportunities for brands to develop customized formulations and delivery systems tailored to specific health conditions and consumer segments. The adoption of advanced technologies, such as nanotechnology and encapsulation, is further enhancing product performance and expanding the range of applications for hemp-derived CBD.

Despite the numerous opportunities, the hemp-derived cannabidiol market faces several restraining factors, with regulatory uncertainty and quality control challenges being the most prominent. The regulatory landscape for CBD products remains fragmented and complex, with significant variations in legal status, permissible concentrations, and labeling requirements across different countries and regions. This lack of harmonization creates compliance challenges for manufacturers and limits the scalability of operations. Quality control issues, such as inconsistent potency, contamination, and mislabeling, have also raised concerns among consumers and regulators, underscoring the need for standardized testing and certification protocols. Addressing these challenges will be critical for ensuring consumer safety, building trust, and sustaining long-term growth in the hemp-derived CBD market.

Regional Outlook

North America continues to lead the global hemp-derived cannabidiol market, capturing a substantial share of USD 4.3 billion in 2024. The region's dominance is underpinned by progressive regulatory frameworks, widespread consumer acceptance, and a vibrant ecosystem of manufacturers, retailers, and research institutions. The United States is the largest market within the region, benefiting from the legalization of industrial hemp, a mature retail infrastructure, and strong demand for wellness and therapeutic products. Canada is also experiencing robust growth, driven by the integration of CBD into both medical and recreational cannabis markets. The North American market is projected to expand at a CAGR of 18.9% through 2033, reaching an estimated USD 21.8 billion by the end of the forecast period.

Europe is emerging as a key growth region for hemp-derived CBD, with a market size of USD 2.7 billion in 2024. The region's growth is fueled by increasing consumer awareness, favorable regulatory changes, and the proliferation of CBD-infused products in mainstream retail channels. The United Kingdom, Germany, Switzerland, and the Netherlands are among the leading markets, supported by a strong tradition of herbal and natural remedies. The European Union's efforts to harmonize regulations and establish quality standards for CBD products are expected to further drive market expansion and enhance consumer confidence. By 2033, the European market is forecasted to reach USD 15.1 billion, reflecting a strong growth trajectory.

The Asia Pacific region, while currently accounting for a smaller share of the global market at USD 1.1 billion in 2024, is poised for rapid growth due to rising health consciousness, urbanization, and evolving regulatory landscapes. Countries such as China, Japan, South Korea, and Australia are witnessing increasing adoption of CBD products, particularly in the personal care and wellness segments. The region's large population base and growing middle class present significant opportunities for market expansion. Latin America and the Middle East & Africa are gradually opening up to hemp-derived CBD, with local players and international brands exploring untapped markets and forming strategic alliances to navigate regulatory complexities.

Hemp-derived Cannabidiol Market Statistics

Competitor Outlook

The global hemp-derived cannabidiol market is characterized by intense competition, with a diverse array of players ranging from established pharmaceutical companies to innovative startups and vertically integrated producers. The competitive landscape is shaped by constant innovation, aggressive marketing strategies, and a relentless focus on quality and safety. Leading companies are investing heavily in research and development to create differentiated products, enhance bioavailability, and expand their portfolios across multiple applications and end-user segments. Strategic mergers, acquisitions, and partnerships are common, as companies seek to strengthen their market positions, access new distribution channels, and accelerate product commercialization.

Brand differentiation and consumer trust are critical success factors in the hemp-derived CBD market. Companies that prioritize transparency, third-party testing, and compliance with regulatory standards are gaining a competitive edge and building loyal customer bases. The increasing importance of sustainability and ethical sourcing is also influencing purchasing decisions, with consumers gravitating toward brands that demonstrate a commitment to environmental stewardship and social responsibility. The emergence of premium and luxury CBD brands is further elevating the competitive dynamics, as companies vie for share in the high-margin segments of the market.

Innovation in product development and marketing is a hallmark of the competitive landscape. Companies are leveraging advanced technologies, such as nanoemulsion and encapsulation, to improve the efficacy and stability of CBD products. The integration of CBD into mainstream consumer goods, such as beverages, cosmetics, and functional foods, is creating new growth opportunities and intensifying competition among both established brands and new entrants. Digital marketing, influencer partnerships, and educational campaigns are being used to engage consumers, build brand awareness, and drive trial and adoption.

Some of the major companies operating in the hemp-derived cannabidiol market include Charlotte’s Web Holdings, Inc., CV Sciences, Inc., Elixinol Global Limited, Canopy Growth Corporation, Aurora Cannabis Inc., Medterra CBD, Green Roads, and Endoca. Charlotte’s Web is renowned for its high-quality CBD oils and tinctures, with a strong focus on transparency and third-party testing. CV Sciences has carved out a niche in the nutraceuticals segment, offering a range of dietary supplements and functional foods. Elixinol Global is recognized for its broad portfolio of CBD products, including skincare, edibles, and pet products, and a strong international presence. Canopy Growth and Aurora Cannabis are leveraging their expertise in cannabis cultivation and processing to develop pharmaceutical-grade CBD products and expand into new markets.

Medterra CBD and Green Roads are prominent players in the U.S. market, known for their extensive product lines, rigorous quality control, and innovative formulations. Endoca, a European leader, is distinguished by its commitment to organic farming and sustainable production practices. These companies, along with a host of emerging startups and regional players, are driving the evolution of the hemp-derived cannabidiol market through continuous innovation, strategic collaborations, and a relentless focus on consumer needs. As the market continues to mature, the competitive landscape is expected to become even more dynamic, with new entrants and disruptive business models reshaping the industry.

Key Players

  • CV Sciences, Inc.
  • Charlotte's Web Holdings, Inc.
  • Medical Marijuana, Inc.
  • ENDOCA
  • Elixinol Global Limited
  • Cannabidiol Life
  • Isodiol International Inc.
  • Green Roads World
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • Medterra CBD
  • Joy Organics
  • Lord Jones
  • Bluebird Botanicals
  • NuLeaf Naturals
  • PharmaHemp
  • CBDistillery
  • HempMeds
  • Folium Biosciences
  • Kazmira LLC
Hemp-derived Cannabidiol Market Overview

Segments

The Hemp-derived Cannabidiol market has been segmented on the basis of

Product Type

  • Oils
  • Tinctures
  • Capsules
  • Topicals
  • Edibles
  • Others

Application

  • Pharmaceuticals
  • Personal Care & Cosmetics
  • Food & Beverages
  • Nutraceuticals
  • Others

Distribution Channel

  • Online Retail
  • Pharmacies
  • Specialty Stores
  • Others

End-User

  • Adults
  • Geriatric
  • Pediatric
  • Others

Competitive Landscape

Major players competing in the North America hemp-derived cannabidiol market are Elixinol; ENDOCA; HempMeds; Kazmira; CV Sciences Inc; Isodiol International Inc; CBD Life; CBD American Shaman; IRIE CBD; Bluebird Botanicals; True Blue; and Groff North America Hemplex.

These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.


For Instance, ENDOCA signed a partnership with Tough Mudder Inc in 2019. Tough Mudder is a lifestyle, media and events company serving sports events for obstacle courses providing in countries including Canada, Germany, United Kingdom, and the United States of America. Through this deal, Tough Mudder becomes ENDOCA’s CBD sponsor and partner for CBD products.

North America Hemp Derived Cannabidiol Market Key Players

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hemp-derived Cannabidiol Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Hemp-derived Cannabidiol Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Hemp-derived Cannabidiol Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Hemp-derived Cannabidiol Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Hemp-derived Cannabidiol Market Size & Forecast, 2023-2032
      4.5.1 Hemp-derived Cannabidiol Market Size and Y-o-Y Growth
      4.5.2 Hemp-derived Cannabidiol Market Absolute $ Opportunity

Chapter 5 Global Hemp-derived Cannabidiol Market Analysis and Forecast By Product Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Product Type
      5.1.2 Basis Point Share (BPS) Analysis By Product Type
      5.1.3 Absolute $ Opportunity Assessment By Product Type
   5.2 Hemp-derived Cannabidiol Market Size Forecast By Product Type
      5.2.1 Oils
      5.2.2 Tinctures
      5.2.3 Capsules
      5.2.4 Topicals
      5.2.5 Edibles
      5.2.6 Others
   5.3 Market Attractiveness Analysis By Product Type

Chapter 6 Global Hemp-derived Cannabidiol Market Analysis and Forecast By Application
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Application
      6.1.2 Basis Point Share (BPS) Analysis By Application
      6.1.3 Absolute $ Opportunity Assessment By Application
   6.2 Hemp-derived Cannabidiol Market Size Forecast By Application
      6.2.1 Pharmaceuticals
      6.2.2 Personal Care & Cosmetics
      6.2.3 Food & Beverages
      6.2.4 Nutraceuticals
      6.2.5 Others
   6.3 Market Attractiveness Analysis By Application

Chapter 7 Global Hemp-derived Cannabidiol Market Analysis and Forecast By Distribution Channel
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Distribution Channel
      7.1.2 Basis Point Share (BPS) Analysis By Distribution Channel
      7.1.3 Absolute $ Opportunity Assessment By Distribution Channel
   7.2 Hemp-derived Cannabidiol Market Size Forecast By Distribution Channel
      7.2.1 Online Retail
      7.2.2 Pharmacies
      7.2.3 Specialty Stores
      7.2.4 Others
   7.3 Market Attractiveness Analysis By Distribution Channel

Chapter 8 Global Hemp-derived Cannabidiol Market Analysis and Forecast By End-User
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End-User
      8.1.2 Basis Point Share (BPS) Analysis By End-User
      8.1.3 Absolute $ Opportunity Assessment By End-User
   8.2 Hemp-derived Cannabidiol Market Size Forecast By End-User
      8.2.1 Adults
      8.2.2 Geriatric
      8.2.3 Pediatric
      8.2.4 Others
   8.3 Market Attractiveness Analysis By End-User

Chapter 9 Global Hemp-derived Cannabidiol Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities By Region
      9.1.2 Basis Point Share (BPS) Analysis By Region
      9.1.3 Absolute $ Opportunity Assessment By Region
   9.2 Hemp-derived Cannabidiol Market Size Forecast By Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis By Region

Chapter 10 Coronavirus Disease (COVID-19) Impact 
   10.1 Introduction 
   10.2 Current & Future Impact Analysis 
   10.3 Economic Impact Analysis 
   10.4 Government Policies 
   10.5 Investment Scenario

Chapter 11 North America Hemp-derived Cannabidiol Analysis and Forecast
   11.1 Introduction
   11.2 North America Hemp-derived Cannabidiol Market Size Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Hemp-derived Cannabidiol Market Size Forecast By Product Type
      11.6.1 Oils
      11.6.2 Tinctures
      11.6.3 Capsules
      11.6.4 Topicals
      11.6.5 Edibles
      11.6.6 Others
   11.7 Basis Point Share (BPS) Analysis By Product Type 
   11.8 Absolute $ Opportunity Assessment By Product Type 
   11.9 Market Attractiveness Analysis By Product Type
   11.10 North America Hemp-derived Cannabidiol Market Size Forecast By Application
      11.10.1 Pharmaceuticals
      11.10.2 Personal Care & Cosmetics
      11.10.3 Food & Beverages
      11.10.4 Nutraceuticals
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis By Application 
   11.12 Absolute $ Opportunity Assessment By Application 
   11.13 Market Attractiveness Analysis By Application
   11.14 North America Hemp-derived Cannabidiol Market Size Forecast By Distribution Channel
      11.14.1 Online Retail
      11.14.2 Pharmacies
      11.14.3 Specialty Stores
      11.14.4 Others
   11.15 Basis Point Share (BPS) Analysis By Distribution Channel 
   11.16 Absolute $ Opportunity Assessment By Distribution Channel 
   11.17 Market Attractiveness Analysis By Distribution Channel
   11.18 North America Hemp-derived Cannabidiol Market Size Forecast By End-User
      11.18.1 Adults
      11.18.2 Geriatric
      11.18.3 Pediatric
      11.18.4 Others
   11.19 Basis Point Share (BPS) Analysis By End-User 
   11.20 Absolute $ Opportunity Assessment By End-User 
   11.21 Market Attractiveness Analysis By End-User

Chapter 12 Europe Hemp-derived Cannabidiol Analysis and Forecast
   12.1 Introduction
   12.2 Europe Hemp-derived Cannabidiol Market Size Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Hemp-derived Cannabidiol Market Size Forecast By Product Type
      12.6.1 Oils
      12.6.2 Tinctures
      12.6.3 Capsules
      12.6.4 Topicals
      12.6.5 Edibles
      12.6.6 Others
   12.7 Basis Point Share (BPS) Analysis By Product Type 
   12.8 Absolute $ Opportunity Assessment By Product Type 
   12.9 Market Attractiveness Analysis By Product Type
   12.10 Europe Hemp-derived Cannabidiol Market Size Forecast By Application
      12.10.1 Pharmaceuticals
      12.10.2 Personal Care & Cosmetics
      12.10.3 Food & Beverages
      12.10.4 Nutraceuticals
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis By Application 
   12.12 Absolute $ Opportunity Assessment By Application 
   12.13 Market Attractiveness Analysis By Application
   12.14 Europe Hemp-derived Cannabidiol Market Size Forecast By Distribution Channel
      12.14.1 Online Retail
      12.14.2 Pharmacies
      12.14.3 Specialty Stores
      12.14.4 Others
   12.15 Basis Point Share (BPS) Analysis By Distribution Channel 
   12.16 Absolute $ Opportunity Assessment By Distribution Channel 
   12.17 Market Attractiveness Analysis By Distribution Channel
   12.18 Europe Hemp-derived Cannabidiol Market Size Forecast By End-User
      12.18.1 Adults
      12.18.2 Geriatric
      12.18.3 Pediatric
      12.18.4 Others
   12.19 Basis Point Share (BPS) Analysis By End-User 
   12.20 Absolute $ Opportunity Assessment By End-User 
   12.21 Market Attractiveness Analysis By End-User

Chapter 13 Asia Pacific Hemp-derived Cannabidiol Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Hemp-derived Cannabidiol Market Size Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Hemp-derived Cannabidiol Market Size Forecast By Product Type
      13.6.1 Oils
      13.6.2 Tinctures
      13.6.3 Capsules
      13.6.4 Topicals
      13.6.5 Edibles
      13.6.6 Others
   13.7 Basis Point Share (BPS) Analysis By Product Type 
   13.8 Absolute $ Opportunity Assessment By Product Type 
   13.9 Market Attractiveness Analysis By Product Type
   13.10 Asia Pacific Hemp-derived Cannabidiol Market Size Forecast By Application
      13.10.1 Pharmaceuticals
      13.10.2 Personal Care & Cosmetics
      13.10.3 Food & Beverages
      13.10.4 Nutraceuticals
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis By Application 
   13.12 Absolute $ Opportunity Assessment By Application 
   13.13 Market Attractiveness Analysis By Application
   13.14 Asia Pacific Hemp-derived Cannabidiol Market Size Forecast By Distribution Channel
      13.14.1 Online Retail
      13.14.2 Pharmacies
      13.14.3 Specialty Stores
      13.14.4 Others
   13.15 Basis Point Share (BPS) Analysis By Distribution Channel 
   13.16 Absolute $ Opportunity Assessment By Distribution Channel 
   13.17 Market Attractiveness Analysis By Distribution Channel
   13.18 Asia Pacific Hemp-derived Cannabidiol Market Size Forecast By End-User
      13.18.1 Adults
      13.18.2 Geriatric
      13.18.3 Pediatric
      13.18.4 Others
   13.19 Basis Point Share (BPS) Analysis By End-User 
   13.20 Absolute $ Opportunity Assessment By End-User 
   13.21 Market Attractiveness Analysis By End-User

Chapter 14 Latin America Hemp-derived Cannabidiol Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Hemp-derived Cannabidiol Market Size Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Hemp-derived Cannabidiol Market Size Forecast By Product Type
      14.6.1 Oils
      14.6.2 Tinctures
      14.6.3 Capsules
      14.6.4 Topicals
      14.6.5 Edibles
      14.6.6 Others
   14.7 Basis Point Share (BPS) Analysis By Product Type 
   14.8 Absolute $ Opportunity Assessment By Product Type 
   14.9 Market Attractiveness Analysis By Product Type
   14.10 Latin America Hemp-derived Cannabidiol Market Size Forecast By Application
      14.10.1 Pharmaceuticals
      14.10.2 Personal Care & Cosmetics
      14.10.3 Food & Beverages
      14.10.4 Nutraceuticals
      14.10.5 Others
   14.11 Basis Point Share (BPS) Analysis By Application 
   14.12 Absolute $ Opportunity Assessment By Application 
   14.13 Market Attractiveness Analysis By Application
   14.14 Latin America Hemp-derived Cannabidiol Market Size Forecast By Distribution Channel
      14.14.1 Online Retail
      14.14.2 Pharmacies
      14.14.3 Specialty Stores
      14.14.4 Others
   14.15 Basis Point Share (BPS) Analysis By Distribution Channel 
   14.16 Absolute $ Opportunity Assessment By Distribution Channel 
   14.17 Market Attractiveness Analysis By Distribution Channel
   14.18 Latin America Hemp-derived Cannabidiol Market Size Forecast By End-User
      14.18.1 Adults
      14.18.2 Geriatric
      14.18.3 Pediatric
      14.18.4 Others
   14.19 Basis Point Share (BPS) Analysis By End-User 
   14.20 Absolute $ Opportunity Assessment By End-User 
   14.21 Market Attractiveness Analysis By End-User

Chapter 15 Middle East & Africa (MEA) Hemp-derived Cannabidiol Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Hemp-derived Cannabidiol Market Size Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Hemp-derived Cannabidiol Market Size Forecast By Product Type
      15.6.1 Oils
      15.6.2 Tinctures
      15.6.3 Capsules
      15.6.4 Topicals
      15.6.5 Edibles
      15.6.6 Others
   15.7 Basis Point Share (BPS) Analysis By Product Type 
   15.8 Absolute $ Opportunity Assessment By Product Type 
   15.9 Market Attractiveness Analysis By Product Type
   15.10 Middle East & Africa (MEA) Hemp-derived Cannabidiol Market Size Forecast By Application
      15.10.1 Pharmaceuticals
      15.10.2 Personal Care & Cosmetics
      15.10.3 Food & Beverages
      15.10.4 Nutraceuticals
      15.10.5 Others
   15.11 Basis Point Share (BPS) Analysis By Application 
   15.12 Absolute $ Opportunity Assessment By Application 
   15.13 Market Attractiveness Analysis By Application
   15.14 Middle East & Africa (MEA) Hemp-derived Cannabidiol Market Size Forecast By Distribution Channel
      15.14.1 Online Retail
      15.14.2 Pharmacies
      15.14.3 Specialty Stores
      15.14.4 Others
   15.15 Basis Point Share (BPS) Analysis By Distribution Channel 
   15.16 Absolute $ Opportunity Assessment By Distribution Channel 
   15.17 Market Attractiveness Analysis By Distribution Channel
   15.18 Middle East & Africa (MEA) Hemp-derived Cannabidiol Market Size Forecast By End-User
      15.18.1 Adults
      15.18.2 Geriatric
      15.18.3 Pediatric
      15.18.4 Others
   15.19 Basis Point Share (BPS) Analysis By End-User 
   15.20 Absolute $ Opportunity Assessment By End-User 
   15.21 Market Attractiveness Analysis By End-User

Chapter 16 Competition Landscape 
   16.1 Hemp-derived Cannabidiol Market: Competitive Dashboard
   16.2 Global Hemp-derived Cannabidiol Market: Market Share Analysis, 2023
   16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      16.3.1 CV Sciences, Inc.
Charlotte's Web Holdings, Inc.
Medical Marijuana, Inc.
ENDOCA
Elixinol Global Limited
Cannabidiol Life
Isodiol International Inc.
Green Roads World
Aurora Cannabis Inc.
Canopy Growth Corporation
Medterra CBD
Joy Organics
Lord Jones
Bluebird Botanicals
NuLeaf Naturals
PharmaHemp
CBDistillery
HempMeds
Folium Biosciences
Kazmira LLC

Methodology

Our Clients

The John Holland Group
FedEx Logistics
Dassault Aviation
Honda Motor Co. Ltd.
Deloitte
General Electric
Microsoft
sinopec